806
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Efficacy of 5α-reductase inhibitors for patients with large benign prostatic hyperplasia (>80 mL) after transurethral resection of the prostate

, , , , , , , , & show all
Pages 238-243 | Received 08 Apr 2015, Accepted 30 Jun 2015, Published online: 30 Jul 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Marcello H. A. Da Silva, Jorge L. Medeiros$suffix/text()$suffix/text(), Waldemar S. Costa, Francisco J. B. Sampaio & Diogo B. De Souza. (2020) Effects of the dutasteride and sildenafil association in the penis of a benign prostatic hyperplasia animal model. The Aging Male 23:5, pages 1009-1015.
Read now
Norelia Torrealba, Gonzalo Rodríguez-Berriguete, Raúl Vera, Benito Fraile, Gabriel Olmedilla, Pilar Martínez-Onsurbe, Manuel Sánchez-Chapado, Ricardo Paniagua & Mar Royuela. (2020) Homeostasis: apoptosis and cell cycle in normal and pathological prostate. The Aging Male 23:5, pages 335-345.
Read now
Abdullah Gul, Serdar Altinay, Levent Kabasakal, Abdulmecit Yavuz, Atilla Semercioz & Ege Can Serefoglu. (2020) Effect of tadalafil on penile nitric oxide synthase and corporal smooth muscle in rats under dutasteride treatment. The Aging Male 23:2, pages 161-167.
Read now
Aldo E. Calogero, Giovanni Burgio, Rosita A. Condorelli, Rossella Cannarella & Sandro La Vignera. (2018) Treatment of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. The Aging Male 21:4, pages 272-280.
Read now
Xiaoqiang Qian, Ding Xu, Hailong Liu, Xiaoling Lin, Yongjiang Yu, Jian Kang, Xujun Sheng, Jianfeng Xu, Siqun Zheng, Danfeng Xu & Jun Qi. (2017) Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist. The Aging Male 20:4, pages 250-256.
Read now
Soner Coban, Omer Gokhan Doluoglu, Ibrahim Keles, Hakan Demirci, Ali Riza Turkoglu, Muhammet Guzelsoy, Mustafa Karalar & Murat Demirbas. (2016) Age and total and free prostate-specific antigen levels for predicting prostate volume in patients with benign prostatic hyperplasia. The Aging Male 19:2, pages 124-127.
Read now

Articles from other publishers (4)

Rebecca A. Campbell & Bradley C. Gill. (2020) Medication Discontinuation Following Transurethral Prostatectomy: an Unrecognized Effectiveness Measure?. Current Urology Reports 21:12.
Crossref
Massimo Nicolò, Lorenzo Ferro Desideri, Aldo Vagge & Carlo Enrico Traverso. (2020) Current Pharmacological Treatment Options for Central Serous Chorioretinopathy: A Review. Pharmaceuticals 13:10, pages 264.
Crossref
Jeffrey Campbell, Jennifer Reid, Michael Ordon & Blayne Welk. (2019) The Utilization of Benign Prostatic Hyperplasia and Bladder-Related Medications After a Transurethral Prostatectomy. Urology 130, pages 126-131.
Crossref
S. Divakar, K. Saravanan, P. Karthikeyan, R. Elancheran, S. Kabilan, K.K. Balasubramanian, Rajlakshmi Devi, J. Kotoky & M. Ramanathan. (2017) Iminoenamine based novel androgen receptor antagonist exhibited anti-prostate cancer activity in androgen independent prostate cancer cells through inhibition of AKT pathway. Chemico-Biological Interactions 275, pages 22-34.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.